Increasing Peer Support for OUD Recovery During COVID-19 Through Digital Health: A National Randomized Controlled Trial

Status: Recruiting
Location: See all (2) locations...
Intervention Type: Behavioral
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The COVID-19 pandemic puts individuals recovering from opioid use disorders (OUDs), an already vulnerable population, at increased risk of overdose due to decreased access to treatment, decreased social support, and increased psychosocial stress. This proposal will test the efficacy of a promising mobile app-based peer support program, compared to usual care, in increasing recovery capital, improving retention in treatment, and reducing psychosocial adverse effects, among a national sample of people in recovery from OUD. If effective, it would provide an accessible, personalized, and scalable approach to OUD recovery increasingly needed during the COVID-19 pandemic.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:

• English-speaking

• Age ≥ 18 years old

• Own their own smartphone

• Self-identifying as being in recovery from or treatment for an opioid use disorder

Locations
United States
Indiana
Indiana University
RECRUITING
Indianapolis
Rhode Island
Brown University School of Public Health
RECRUITING
Providence
Contact Information
Primary
Francesca L Beaudoin, MD, PhD
mps_study@brown.edu
401-863-7200
Backup
Alyssa Peachey, MHA
mps_study@brown.edu
Time Frame
Start Date: 2022-05-12
Estimated Completion Date: 2027-03
Participants
Target number of participants: 1300
Treatments
Experimental: Marigold APP
Participants randomized to receive the APP will be enrolled in an app based peer support program
No_intervention: CONTROL
In the control arm participants will receive existing standardized peer recovery support resources from SAMHSA
Related Therapeutic Areas
Sponsors
Collaborators: Indiana University, National Institute on Drug Abuse (NIDA), National Institutes of Health (NIH)
Leads: Brown University

This content was sourced from clinicaltrials.gov